01349.HK
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.37
−0.21%Next report
Analyst consensus
- Next report date
- Oct 30, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 17, 2026
- EPS actual
- HKD 0.03
- EPS estimate
- —
- Revenue actual
- HKD 256.7M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 17, 2026 | — | HKD 0.03 | — | HKD 256.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 30, 2026